Welcome to our dedicated page for Hyperion DeFi SEC filings (Ticker: HYPD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hyperion DeFi, Inc. (NASDAQ: HYPD) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered tools to help interpret them. Hyperion DeFi’s filings describe its evolution from an ophthalmic technology company into a Hyperliquid-native DeFi business that builds and deploys a long-term strategic treasury of HYPE, the native token of the Hyperliquid blockchain, while continuing development of its Optejet User Filled Device.
Investors can review Form 8-K current reports that detail material events such as at-the-market equity program amendments, Sales Agreements with investment banks, HAUS agreements with DeFi partners, and the Joint Validator Operators’ Agreement for the Kinetiq × Hyperion validator node. Other 8-K filings describe leadership changes, including appointments of key executives, and press releases furnishing quarterly financial results and investor presentations.
Annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) typically provide a broader view of Hyperion DeFi’s business model, including its digital asset treasury strategy, revenue components such as staking rewards, validator commissions, yield enhancement, DeFi monetization, and ecosystem rewards, as well as its ongoing life sciences activities around the Optejet User Filled Device. Proxy statements on Schedule 14A can offer additional detail on governance, board composition, and executive compensation.
On Stock Titan, these filings are updated in near real time as they are posted to the SEC’s EDGAR system. AI-powered summaries highlight key points from lengthy documents, helping readers understand how new agreements, capital raises, or digital asset strategies may affect Hyperion DeFi’s operations and risk profile. Users can also review Form 4 insider transaction reports to see how directors and officers are trading HYPD shares, and use AI explanations to interpret complex disclosures without wading through full-text filings.
Hyperion DeFi, Inc. reported insider share purchases by a director. A Form 4 filing shows open-market buys of 18,742 shares of common stock on 12/18/2025 at a volume-weighted average price of $3.1389 per share and an additional 19,702 shares at a volume-weighted average price of $3.1385 per share. These prices reflect multiple trades executed between $3.04 and $3.22 per share. Following these transactions, the reporting person beneficially owns 75,448 shares directly and 95,150 shares indirectly through a spouse.
Hyperion DeFi, Inc. entered into a Sales Agreement allowing an at-the-market offering of up to $500,000,000 of common stock under its Form S-3 shelf registration. The company can instruct Cantor Fitzgerald & Co. and Chardan Capital Markets, LLC to sell shares from time to time through regular market trades, block trades, or other permitted methods on The Nasdaq Capital Market or elsewhere. The Sales Agents will use commercially reasonable efforts to place the stock and will receive a commission equal to 4.0% of the gross sales proceeds for shares sold. Hyperion DeFi is not required to sell any shares, and the program will end when all authorized shares are sold or the agreement is terminated.
Hyperion DeFi, Inc. has filed a Form S-3 shelf registration to offer up to $1,000,000,000 of securities, including common stock, preferred stock, warrants, debt securities, units and rights, in one or more future offerings. Within this, a separate sales agreement prospectus covers up to $500,000,000 of common stock that may be issued from time to time through at-the-market transactions under a Sales Agreement with Cantor Fitzgerald & Co. and Chardan Capital Markets, LLC. The company’s common stock trades on Nasdaq under the symbol HYPD and last closed at $4.97 per share on November 13, 2025. As of September 30, 2025, Hyperion DeFi had 7,162,659 shares of common stock, 5,435,897 shares of Series A Preferred Stock and warrants to purchase 33,820,785 shares outstanding.
Hyperion DeFi, formerly Eyenovia, is building a strategic treasury of HYPE tokens tied to the Hyperliquid blockchain while operating a validator and related DeFi services, and it continues to develop its Optejet ophthalmic liquid delivery device. The company is a smaller reporting company and may use net proceeds from any future sales for general corporate purposes such as working capital, capital expenditures, debt repayment and potential acquisitions, with specific uses to be detailed in later prospectus supplements.
Hyperion DeFi, Inc. reported a sharp turnaround in Q3 2025 as it pivoted to a digital‑asset treasury strategy centered on HYPE tokens. Net income was $6.6 million for the quarter, compared with a loss a year ago, driven by realized and unrealized gains on HYPE and a gain on extinguishment of liabilities. Revenue reached $302,506 from native staking and validator commissions. Cash was $8.2 million, total assets $82.8 million, and stockholders’ equity improved to $70.8 million.
The company raised capital through an ATM and a private placement, including $50.0 million of Series A Preferred Stock with accompanying warrants, and expanded authorized shares. It began acquiring and staking HYPE in July, ending the quarter with HYPE digital assets of $37.95 million and digital intangible assets (primarily HiHYPE) of $35.02 million, offset by a $6.29 million impairment. The Avenue loan was amended to extend maturity to July 1, 2028, reduce the rate to 8% (half cash/half PIK), and add warrants. Common shares outstanding were 7,162,659 as of September 30, 2025; 8,097,659 as of November 10, 2025.
Hyperion DeFi, Inc. announced its financial results for the quarter ended September 30, 2025. The company made a press release available and provided an investor presentation to accompany the disclosure.
Hyperion DeFi is hosting a conference call on November 13, 2025 to discuss its quarterly financial and operating results. The company’s common stock trades on the Nasdaq Capital Market under the symbol HYPD.
Hyperion DeFi (HYPD) filed an 8-K detailing two blockchain operating agreements and a leadership change. The company entered a Joint Validator Operators’ Agreement with Kinetiq Research and Pier Two, effective retroactively to June 25, 2025, to run a co-branded validator on the Hyperliquid Layer-1. Hyperion initiated the validator with 10,000 HYPE and will provide staking capital from its HYPE treasury. Kinetiq supplies operations support and tooling, while Pier Two hosts and manages infrastructure with ISO/IEC 27001 and SOC 2 compliance.
The agreement includes revenue sharing of validator-level rewards, quorum-based key management, service levels, and slashing risk provisions. It runs for an initial one-year term with automatic annual renewals and 90 days’ termination notice, with additional default and force majeure rights. Separately, Hyperion signed a HAUS Agreement with Felix Foundation to allocate 500,000 HYPE to a joint wallet to meet HIP-3 requirements for launching a perpetual futures market, under which Hyperion receives tiered market revenues plus 100% of staking rewards; the term is 52 weeks with 26-week auto-renewals and 30 days’ notice. The previously announced CEO resignation takes effect on November 1, 2025.
Hyperion DeFi, Inc. reported a change in its leadership structure. On September 30, 2025, board member Michael Rowe submitted his resignation from the company’s Board of Directors. The filing does not provide additional context about his departure, but it means the board will continue its responsibilities without his participation going forward.
The report is signed by Interim Chief Executive Officer Hyunsu Jung, indicating that the company is already operating under interim executive leadership. This type of update focuses on corporate governance and informs shareholders about who is currently involved in the company’s oversight.
Insider reported receipt of restricted stock units totaling 300,000 shares of Hyperion DeFi, Inc. (HYPD). David R. Knox, identified as a director and the company's Chief Financial Officer, reported two grants dated 09/29/2025 that together increase his direct beneficial ownership to 300,000 shares.
The first grant covers 100,000 RSUs vesting in two equal tranches of 50,000 on 03/29/2026 and 09/29/2026, subject to continued employment. The second grant covers 200,000 RSUs that vest upon achieving market-cap milestones: 100,000 RSUs at $150 million and 100,000 RSUs at $500 million, each measured as the threshold met on ten trading days within a rolling 30-day period, subject to continued employment. All reported transactions have a $0 price.
David R. Knox, serving as Chief Financial Officer and a director of Hyperion DeFi, Inc. (ticker: HYPD), filed an initial Form 3 reporting his status as an officer and director. The reporting event date is 09/29/2025. The filing lists Mr. Knox's address in Laguna Hills, CA and includes a Power of Attorney as Exhibit 24.
The Form 3 discloses that no securities are beneficially owned by Mr. Knox at the time of filing. The document is signed by Mr. Knox on 10/01/2025. This Form 3 is a routine Section 16 filing notifying the market of an officer/director relationship and the absence of any current direct or indirect equity holdings in the issuer.
Hyperion DeFi, Inc. (HYPD) filed an 8-K reporting officer-level changes and exhibits. The filing lists Item 5.02 (departure/election/appointment/compensatory arrangements) and Item 9.01 (financial statements and exhibits). It identifies an Employment Agreement dated September 8, 2025 between Hyperion DeFi, Inc. and David Knox, and a press release dated September 29, 2025 as exhibits. The filing is signed by Hyunsu Jung.
The document provides the existence and dates of the employment agreement and press release but does not include the agreement’s terms, compensation details, or narrative disclosure in the text provided.